12-110858713-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_152591.3(CCDC63):āc.307A>Gā(p.Lys103Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_152591.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC63 | NM_152591.3 | c.307A>G | p.Lys103Glu | missense_variant | 4/12 | ENST00000308208.10 | NP_689804.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC63 | ENST00000308208.10 | c.307A>G | p.Lys103Glu | missense_variant | 4/12 | 2 | NM_152591.3 | ENSP00000312399.5 | ||
CCDC63 | ENST00000552694.1 | c.70A>G | p.Lys24Glu | missense_variant | 2/10 | 1 | ENSP00000450217.1 | |||
CCDC63 | ENST00000550317.1 | n.465A>G | non_coding_transcript_exon_variant | 2/4 | 1 | |||||
CCDC63 | ENST00000545036.5 | c.187A>G | p.Lys63Glu | missense_variant | 3/11 | 2 | ENSP00000445881.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251404Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135876
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727218
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 30, 2024 | The c.307A>G (p.K103E) alteration is located in exon 4 (coding exon 3) of the CCDC63 gene. This alteration results from a A to G substitution at nucleotide position 307, causing the lysine (K) at amino acid position 103 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at